2013
DOI: 10.1016/j.transproceed.2013.08.098
|View full text |Cite
|
Sign up to set email alerts
|

Cytomegalovirus Infectıon in Renal Transplant Recipients: One Center's Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
12
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 17 publications
4
12
0
Order By: Relevance
“…A longer duration of GCV treatment in patients receiving Tac may indicate its greater immunosuppressive potential. Our observation is confirmed by the results obtained by other authors [4].…”
Section: Discussionsupporting
confidence: 93%
“…A longer duration of GCV treatment in patients receiving Tac may indicate its greater immunosuppressive potential. Our observation is confirmed by the results obtained by other authors [4].…”
Section: Discussionsupporting
confidence: 93%
“…Hepatitis B virus and hepatitis C virus positivity was seen in one patient each (2/7 cases, 28.6%). A recent study from Turkey revealed positive hepatitis B and C serology in 17.6% of CMV positive cases (14). Another study found HCV positivity in 28.6% of CMV positive recipients (15).…”
Section: Cytomegalovirusmentioning
confidence: 96%
“…Alternatively UTI can reactivate latent CMV virus by releasing pro-inflammatory cytokines which trigger CMV replication (16). Urine leucocyte counts were also found to be higher in CMV positive recipients (14). Further research is essential to understand the link between UTIs and CMV infection.…”
Section: Cytomegalovirusmentioning
confidence: 99%
See 1 more Smart Citation
“…We found that HLA-B48 and HLA-B57 have a significant influence in CMV disease after transplantation and HLA-DRB1*09 indicates the opposite results. In the literature, HLA alleles are recognized as risk factors for CMV disease, but some of them can have a protective role [16][17][18][19], and this situation might be useful pretransplant in estimating the risk of CMV disease after transplantation and designing individualized therapy. A better understanding of the different HLA associated immune mechanism within CMV disease may lead to improved management strategies in kidney transplantation.…”
Section: Letter To the Editormentioning
confidence: 99%